Profil
Richard van Steen is associated with Life Science Pharmaceuticals, Inc. as a Director & Vice President since 2006.
He is the founder of Life Science Pharmaceuticals, Inc. which was founded in 2006.
Postes actifs de Richard van Steen
Sociétés | Poste | Début |
---|---|---|
Life Science Pharmaceuticals, Inc.
Life Science Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT). | Fondateur | 01/01/2006 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Life Science Pharmaceuticals, Inc.
Life Science Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT). | Health Technology |